# A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis

> **NCT02740231** · PHASE2,PHASE3 · COMPLETED · sponsor: **Bone Therapeutics S.A** · enrollment: 173 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **DRUG:** JTA-004 intra-articular injection
- **DEVICE:** Reference product intra-articular injection

## Key facts

- **NCT ID:** NCT02740231
- **Lead sponsor:** Bone Therapeutics S.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2018-04-27
- **Final completion:** 2018-04-27
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740231, "A Study on Visco-antalgic Intra-articular Administration in Symptomatic Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02740231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*